Neurology

Cosmos Health CEO Greg Siokas Issues Letter to Shareholders Highlighting Record 2026 Revenue, U.S. Subscription Growth and Global Expansion

Key HighlightsRecord revenue: preliminary nine-month 2026 revenue of approximately $54.3 million, up 19%, with every quarter of 2026 setting a...

FDA approves Roche’s Enspryng, a first-in-class IL-6R inhibitor, as the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)

FDA approval based on Phase III SatraGO-1 and -2 studies, with SatraGO-2 demonstrating a significant reduction in eye bulging (proptosis)...

Baylor Genetics Study Finds Genome Sequencing Identifies Genetic Diagnoses in Nearly One-Third of Children with Intellectual Disability and Developmental Delay

HOUSTON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive...

Roche presents new Phase III one-year data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss

In the MEERKAT and SANDCAT studies, vamikibart demonstrated sustained improvements in vision and reductions in macular thickness in patients with...

New Study Shows Cortical Disarray Measurement (CDM®) Can Reflect Microscopic Patterns of Pathology in Frontotemporal Dementia

Research presented at ISFTD 2026 connects measurements from the living brain with disease patterns confirmed through postmortem analysis Mapping cortical...

UpRight Science Brings Together Expert Advisory Board to Advance Balance as an Essential Health Measure

Multidisciplinary group brings expertise across medicine, neuroscience, healthcare technology, business, and communications to support the company's mission to make balance...

BRAINBox Solutions Announces Agreement with Prolight Diagnostics for Commercial Supply of Pyros® Devices for Delivery of BRAINBox Concussion Diagnostics/Prognostics at Point-of-Care

Company reports additional progress in expanding its patent portfolio for concussion and neurodegenerative disease testingRICHMOND, Va., Sept. 14, 2026 /PRNewswire/...

error: Content is protected !!